Circulating levels of MCP‐1, sIL‐2R, IL‐15, and IL‐8 predict anemia response to pomalidomide therapy in myelofibrosis (Q45916590)
Jump to navigation
Jump to search
scientific article published on April 1, 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Circulating levels of MCP‐1, sIL‐2R, IL‐15, and IL‐8 predict anemia response to pomalidomide therapy in myelofibrosis |
scientific article published on April 1, 2011 |
Statements
1 reference
Circulating levels of MCP‐1, sIL‐2R, IL‐15, and IL‐8 predict anemia response to pomalidomide therapy in myelofibrosis (English)
1 reference
Circulating levels of MCP-1, sIL-2R, IL-15, and IL-8 predict anemia response to pomalidomide therapy in myelofibrosis (English)
Ayalew Tefferi
1 reference
Animesh Pardanani
1 reference
Kebede Begna
1 reference
Christy Finke
1 reference
Terra Lasho
1 reference
1 April 2011
1 reference
1 reference
86
1 reference
4
1 reference
343-345
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference